Abstract
Acute kidney injury (AKI) and chronic kidney disease (CKD) are common and profound issues for human health. Functional biomarkers such as serum creatinine (Scr) have been used as diagnostic indexes for AKI and CKD. In AKI, however, kidney damage precedes functional change. Therefore, novel biomarker candidates have been explored using urine sample. Among these candidates, neutrophil gelatinase-associated lipocalin, liver-type fatty acid-binding protein, interleukin-18, and kidney injury molecule-1 are well examined in patients with AKI in specific clinical settings. Furthermore, besides albuminuria known as the established biomarker in CKD, the usefulness of these urinary biomarkers in CKD is also being recognized. The general use of urinary biomarkers for AKI and CKD has not been qualified, but the incorporation must help understand the renal condition. Meanwhile, when the alteration in urinary biomarkers is evaluated, the fluctuation of urine volume (UV) should be corrected because the fluctuation causes the varied concentration of urinary biomarkers. Urinary biomarker excretion rate (UBER) corrected by UV itself is known as a gold standard method and is calculated as a product of urinary biomarker concentration and UV, which requires timed urine collection. Alternatively, urinary biomarker-to-creatinine ratio (UBCR) corrected by urinary creatinine is used to substitute UBER and is calculated as a quotient of dividing urinary biomarker concentration by urinary creatinine concentration, for which spot urine is available. In the case that creatinine kinetics is under a nonsteady state, UBCR is influenced in a positive and negative way. As a positive way, the reliability of UBCR to detect kidney damage can be enhanced due to the decreased urinary creatinine. As a negative way, the change of UBCR is offset due to the increased urinary creatinine, resulting in the overlook of kidney damage. Therefore, the influence of the nonsteady state of creatinine on the kinetics should be considered when the alteration in urinary biomarkers is evaluated.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- ACR:
-
Albumin-to-Creatinine Ratio
- ADQI:
-
Acute Dialysis Quality Initiative
- AER:
-
Albumin Excretion Rate
- AKI:
-
Acute Kidney Injury
- AKIN:
-
Acute Kidney Injury Network
- ARF:
-
Acute Renal Failure
- BUN:
-
Blood Urea Nitrogen
- Ccr:
-
Creatinine Clearance
- Cin:
-
Inulin Clearance
- CKD:
-
Chronic Kidney Disease
- CKD-EPI:
-
Chronic Kidney Disease Epidemiology Collaboration
- CysC:
-
Cystatin C
- ER:
-
Endoplasmic Reticulum
- FA:
-
Fatty Acid
- FABP:
-
Fatty Acid-Binding Protein
- GFcr:
-
Glomerular-Filtrated Creatinine
- GFin:
-
Glomerular-Filtrated Inulin
- GFR:
-
Glomerular Filtration Rate
- IL18:
-
Interleukin-18
- KDIGO:
-
Kidney Disease: Improving Global Outcomes
- KIM-1:
-
Kidney Injury Molecule-1
- L-FABP:
-
Liver-Type Fatty Acid-Binding Protein
- MATE1:
-
Multidrug and Toxin Extrusion-1
- MDRD:
-
Modification of Diet in Renal Disease
- NGAL:
-
Neutrophil Gelatinase-Associated Lipocalin
- OAT:
-
Organic Anion Transporter
- OCT2:
-
Organic Cation Transporter-2
- Scr:
-
Serum Creatinine
- Sin:
-
Serum Inulin
- TScr:
-
Tubular-Secreted Creatinine
- UBCR:
-
Urinary Biomarker-to-Creatinine Ratio
- UBER:
-
Urinary Biomarker Excretion Rate
- UBM:
-
Urinary Biomarker
- Ucr:
-
Urinary Creatinine
- Uin:
-
Urinary Inulin
- UV:
-
Urine Volume
References
Ali T, Khan I, Simpson W, et al. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol. 2007;18:1292–8.
Anders HJ, Muruve DA. The inflammasomes in kidney disease. J Am Soc Nephrol. 2011;22:1007–18.
Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R204–12.
Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41.
Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–47.
Cruz DN, Ricci Z, Ronco C. Clinical review: RIFLE and AKIN – time for reappraisal. Crit Care. 2009;13:211.
Dieterle F, Sistare F, Goodsaid F, et al. Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium. Nat Biotechnol. 2010;28:455–62.
Donohoe JF, Venkatachalam MA, Bernard DB, et al. Tubular leakage and obstruction after renal ischemia: structural-functional correlations. Kidney Int. 1978;13:208–22.
Edelstein CL, Hoke TS, Somerset H, et al. Proximal tubules from caspase-1-deficient mice are protected against hypoxia-induced membrane injury. Nephrol Dial Transplant. 2007;22:1052–61.
Endre ZH, Kellum JA, Di Somma S, et al. Differential diagnosis of AKI in clinical practice by functional and damage biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference. Contrib Nephrol. 2013;182:30–44.
Fenton RA. Essential role of vasopressin-regulated urea transport processes in the mammalian kidney. Pflugers Arch. 2009;458:169–77.
Guo L, Takino T, Endo Y, et al. Shedding of kidney injury molecule-1 by membrane-type 1 matrix metalloproteinase. J Biochem. 2012;152:425–32.
Harvey AM, Malvin RL, Vander AJ. Comparison of creatinine secretion in men and women. Nephron. 1966;3:201–5.
Herget-Rosenthal S, Marggraf G, Hüsing J, et al. Early detection of acute renal failure by serum cystatin C. Kidney Int. 2004;66:1115–22.
Hsu CY, McCulloch CE, Fan D, et al. Community-based incidence of acute renal failure. Kidney Int. 2007;72:208–12.
Humphreys BD, Czerniak S, DiRocco DP, et al. Repair of injured proximal tubule does not involve specialized progenitors. Proc Natl Acad Sci U S A. 2011;108:9226–31.
Hvidberg V, Jacobsen C, Strong RK, et al. The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake. FEBS Lett. 2005;579:773–7.
Ichimura T, Asseldonk EJ, Humphreys BD, et al. Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J Clin Invest. 2008;118:1657–68.
Karbach U, Kricke J, Meyer-Wentrup F, et al. Localization of organic cation transporters OCT1 and OCT2 in rat kidney. Am J Physiol Renal Physiol. 2000;279:F679–87.
Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1–138.
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150.
Kuwabara T, Mori K, Mukoyama M, et al. Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons. Kidney Int. 2009;75:285–94.
Lafrance JP, Miller DR. Acute kidney injury associates with increased long-term mortality. J Am Soc Nephrol. 2010;21:345–52.
Lee DB, Huang E, Ward HJ. Tight junction biology and kidney dysfunction. Am J Physiol Renal Physiol. 2006;290:F20–34.
Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–70.
Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–12.
Lim AI, Chan LY, Lai KN, et al. Distinct role of matrix metalloproteinase-3 in kidney injury molecule-1 shedding by kidney proximal tubular epithelial cells. Int J Biochem Cell Biol. 2012;44:1040–50.
Maatman RG, Van Kuppevelt TH, Veerkamp JH. Two types of fatty acid-binding protein in human kidney. Isolation, characterization and localization. Biochem J. 1991;273:759–66.
Masuda S, Terada T, Yonezawa A, et al. Identification and functional characterization of a new human kidney-specific H+/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2. J Am Soc Nephrol. 2006;17:2127–35.
McCullough PA, Shaw AD, Haase M, et al. Diagnosis of acute kidney injury using functional and injury biomarkers: workgroup statements from the tenth acute dialysis quality initiative consensus conference. Contrib Nephrol. 2013;182:13–29.
Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.
Melnikov VY, Ecder T, Fantuzzi G, et al. Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. J Clin Invest. 2001;107:1145–52.
Moran SM, Myers BD. Course of acute renal failure studied by a model of creatinine kinetics. Kidney Int. 1985;27:928–37.
Murray PT, Devarajan P, Levey AS, et al. A framework and key research questions in AKI diagnosis and staging in different environments. Clin J Am Soc Nephrol. 2008;3:864–8.
Newman DJ. Cystatin C. Ann Clin Biochem. 2002;39:89–104.
Obregon C, Dreher D, Kok M, et al. Human alveolar macrophages infected by virulent bacteria expressing SipB are a major source of active interleukin-18. Infect Immun. 2003;71:4382–8.
Ostermann M, Chang R, Riyadh ICU Program Users Group. Correlation between the AKI classification and outcome. Crit Care. 2008;12:R144.
Paragas N, Qiu A, Hollmen M, et al. NGAL-Siderocalin in kidney disease. Biochim Biophys Acta. 2012;1823:1451–8.
Shemesh O, Golbetz H, Kriss JP, et al. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int. 1985;28:830–8.
Takuwa S, Ito Y, Ushijima K, et al. Serum cystatin-C values in children by age and their fluctuation during dehydration. Pediatr Int. 2002;44:28–31.
Tanihara Y, Masuda S, Sato T, et al. Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H(+)-organic cation antiporters. Biochem Pharmacol. 2007;74:359–71.
Tonomura Y, Uehara T, Yamamoto E, et al. Decrease in urinary creatinine in acute kidney injury influences diagnostic value of urinary biomarker-to-creatinine ratio in rats. Toxicology. 2011;290:241–8.
Tonomura Y, Morikawa Y, Takagi S, et al. Underestimation of urinary biomarker-to-creatinine ratio resulting from age-related gain in muscle mass in rats. Toxicology. 2013;303:169–76.
Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol. 2001;2:285–93.
Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294:813–8.
Urakami Y, Kimura N, Okuda M, et al. Creatinine transport by basolateral organic cation transporter hOCT2 in the human kidney. Pharm Res. 2004;21:976–81.
Vallon V, Eraly SA, Rao SR, et al. A role for the organic anion transporter OAT3 in renal creatinine secretion in mice. Am J Physiol Renal Physiol. 2012;302:F1293–9.
Vanmassenhove J, Vanholder R, Nagler E, et al. Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature. Nephrol Dial Transplant. 2013;28:254–73.
Yamamoto T, Noiri E, Ono Y, et al. Renal L-type fatty acid-binding protein in acute ischemic injury. J Am Soc Nephrol. 2007;18:2894–902.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media Dordrecht
About this entry
Cite this entry
Tonomura, Y., Matsubara, M., Kazama, I. (2015). Biomarkers in Urine and Use of Creatinine. In: Preedy, V., Patel, V. (eds) General Methods in Biomarker Research and their Applications. Biomarkers in Disease: Methods, Discoveries and Applications. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-7696-8_18
Download citation
DOI: https://doi.org/10.1007/978-94-007-7696-8_18
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-7695-1
Online ISBN: 978-94-007-7696-8
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences